TuHURA Biosciences, Inc.
HURA
$2.22
-$0.07-3.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.22M | 12.66M | 19.60M | 3.67M | |
| Total Receivables | 515.20K | 642.40K | 359.30K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 7.59M | 6.31M | 6.77M | -- | |
| Total Current Assets | 14.33M | 19.61M | 26.72M | -- | |
|
|
|||||
| Total Current Assets | 14.33M | 19.61M | 26.72M | -- | |
| Net Property, Plant & Equipment | 313.30K | 322.50K | 355.70K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 33.80K | 33.80K | -- | |
| Total Assets | 14.64M | 19.97M | 27.11M | -- | |
|
|
|||||
| Total Accounts Payable | 3.08M | 3.15M | 1.33M | -- | |
| Total Accrued Expenses | 1.53M | 2.02M | 1.09M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 164.60K | 159.80K | 155.20K | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | 2.85M | -- | |
| Total Other Current Liabilities | -- | -- | 2.85M | -- | |
| Total Current Liabilities | 4.78M | 5.33M | 5.43M | -- | |
|
|
|||||
| Total Current Liabilities | 4.78M | 5.33M | 5.43M | -- | |
| Long-Term Debt | -- | -- | 24.37M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | 42.70K | 84.30K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 4.78M | 5.37M | 29.88M | -- | |
|
|
|||||
| Common Stock & APIC | 130.43M | 125.44M | 102.35M | -- | |
| Retained Earnings | -117.79M | -111.12M | -105.13M | -- | |
| Treasury Stock & Other | -3.06M | -- | -- | -- | |
| Total Common Equity | 9.58M | 14.32M | -2.78M | -1.58M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 278.50K | 278.50K | 8.10K | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 278.50K | 278.50K | 8.10K | 16.90K | |
|
|
|||||
| Total Common Equity | 9.58M | 14.32M | -2.78M | -1.58M | |
| Total Preferred Equity | 278.50K | 278.50K | 8.10K | 16.90K | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 9.86M | 14.59M | -2.77M | -1.56M | |
|
|
|||||